A cobalt(III) complex,
[Co(L)]Cl (complex
1
, where
L = 1,8-[
N
,
N
-bis{(3-formyl-2-hydroxy-5-methyl)benzyl}]-1,4,8,11-tetraaza-5,5,7,12,12,14-hexamethylcyclotetradecane)
with distorted octahedral geometry has been synthesized and characterized
using various spectroscopic techniques. The structure of the ligand
has remarkably rich hydrogen intermolecular interactions such as H···H,
H···C/C···H, and H···O/O···H
that vary with the presence of the metal ion, and the structure of
complex
1
has Cl···H interactions; this
result has been proved by Hirshfeld surface and two-dimensional (2D)
fingerprint maps analyses. The complex exhibits a quasi-reversible
Co(III)/Co(II) redox couple with
E
1/2
=
−0.76 V. Calf thymus DNA (CT DNA) binding abilities of the
ligand and complex
1
were confirmed by spectroscopic
and electrochemical analyses. According to absorption studies, the
ligand and complex
1
bind to CT DNA via intercalative
binding mode, with intrinsic binding strengths of 1.41 × 10
3
and 8.64 × 10
3
M
–1
, respectively.
A gel electrophoresis assay shows that complex
1
promotes
the pUC19 DNA cleavage under dark and light irradiation conditions.
Complex
1
has superior antimicrobial activity than the
ligand. The cytotoxicity of complex
1
was tested against
MDA-MB-231 breast cancer cells with values of IC
50
of 1.369
μg mL
–1
in the dark and 0.9034 μg mL
–1
after light irradiation. Besides, cell morphological
studies confirmed the morphological changes with AO/EB dual staining,
reactive oxygen species (ROS) staining, mitochondria staining, and
Hoechst staining on MDA-MB-231 cancer cells by fluorescence microscopy.
Complex
1
was found to be a potent antiproliferative
agent against MDA-MB-231 cells, and it can induce mitochondrial-mediated
and caspase-dependent apoptosis with activation of downregulated caspases.
The biotoxicity assay of complex
1
on the development
of
Artemia nauplii
was evaluated at
an IC
50
value of 200 μg mL
–1
and
with excellent biocompatibility.